Tag Archives: Pfizer/BioNTech vaccine

Tracy Hussell, University of Manchester Late last year, I asked: is it safe to have more than one type of COVID-19 vaccine? A trial has now addressed that question, as well as what effect combining different vaccine types has on immunity. Most COVID-19 vaccines require two doses, and the usual strategy is to give people the same vaccine type for …

Rebecca Aicheler, Cardiff Metropolitan University Vaccination is the safest way to gain immunity to the coronavirus, and with most COVID-19 vaccines, you need two doses to get the greatest possible protection. Immunologists call this method of giving people multiple doses “prime-boosting”. Essentially, you first teach the immune system what it is looking for – you prime it with the first …

One of this and one of that might be a good strategy to coronavirus vaccination. SOPA Images/LightRocket via Getty Images Maureen Ferran, Rochester Institute of Technology While it’s now pretty easy to get a COVID-19 shot in most places in the U.S., the vaccine rollout in other parts of the world has been slow or inconsistent due to shortages, uneven …

Dominic Wilkinson, University of Oxford; Jonathan Pugh, University of Oxford, and Julian Savulescu, University of Oxford Moderna and Pfizer have released data suggesting that their vaccines are well tolerated in adolescents and highly effective in preventing COVID-19. Canada, the US and the EU have already authorised the Pfizer vaccine in children as young as 12. And the UK has just …

Jennifer Juno, The Peter Doherty Institute for Infection and Immunity and Adam Wheatley, The University of Melbourne Since COVID-19 vaccines began rolling out across the world, many scientists have been hesitant to say they can reduce transmission of the virus. Their primary purpose is to prevent you from getting really sick with the virus, and it quickly became clear the …

Rory Horner, University of Manchester COVID-19 vaccination programmes are gathering pace in high-income countries, but for much of the world, the future looks bleaker. Although a number of middle-income countries have started rolling out vaccines, widespread vaccination could still be years away. The first two COVID-19 vaccines authorised in Europe and the United States – made by Pfizer/BioNTech and Moderna …

I am a physician, and I just got my first shot of the Pfizer COVID-19 vaccine. William Petri, CC BY-SA William Petri, University of Virginia This week I was vaccinated against COVID-19 with the Pfizer mRNA vaccine, which brought to mind some frequently asked questions about the Pfizer and Moderna vaccines. I am a professor of infectious diseases at the …

Rob Reddick, The Conversation Coronavirus vaccines are being administered. Pfizer’s COVID-19 vaccine was the first to finish the final stage of testing – known as phase 3 – and the full results have been published. Having assessed the data, countries are beginning to authorise this vaccine for public use and roll it out. Others are not too far behind. The …

Rob Reddick, The Conversation Coronavirus vaccines are being administered. Pfizer’s COVID-19 vaccine was the first to finish the final stage of testing – known as phase 3 – and the full results have been published. Having assessed the data, countries are beginning to authorise this vaccine for public use and roll it out. Others are not too far behind. The …

Jasmina Panovska-Griffiths, UCL The first people have begun to receive vaccines in the UK and US as part of mass vaccination campaigns to immunise people against COVID-19. Excitement is building – finally, the end of the coronavirus crisis is in sight. Since early December, elderly patients and health workers in 50 hospitals across the UK have been given the vaccine …